Recent advances in prostate cancer radiotherapy have prioritized techniques that minimize treatment-related toxicity and ...

Blue Earth Therapeutics, a clinical-stage radiopharmaceutical company and University College London (UCL) today announced initiation of a Phase 1 clinical trial (NCT07414940) evaluating Actinium ...

For Gary Buchanan, pickleball is more than a game; it's a place where, for a few hours, he can set aside the reality of living with stage 4 cancer.

The Stockholm3 model combines PSA, plasma protein biomarkers, polygenic risk, and clinical factors for prostate cancer screening.

The $6m investment expands the group's healthcare portfolio. Boustead Singapore is expanding its healthcare technology ...

Exact Imaging is looking to broaden uptake of its high-resolution micro-ultrasound system for prostate cancer screening and ...

The committee that decided to ration prostate cancer screening earlier this year does not contain a single expert on the disease, it has been claimed.

Researchers identify epigenetic mechanism that explains why some prostate cancers grow slowly and remain localized but others ...

A growing number of prostate cancer experts argue that calling the lowest-risk prostate cancer "cancer" does more harm than good. A new UCLA-led study found removing the cancer label could ...

For many men, a prostate cancer scare starts with one number. A PSA result comes back high, and ...